Omeprazole

BreastfeedingPediatric
  • TRADE NAMES: Antra; Audazol; Gastroloc; Inhibitron; Logastric; Losec; Mopral; Omed; Ozoken; Parizac; Prilosec (AstraZeneca); Ulsen; Yosprala (Aralez)
  • INDICATIONS: Duodenal ulcer, gastric ulcer, gastroesophageal reflux disease (GERD), erosive esophagitis
  • CLASS: CYP1A2 inducer, Proton pump inhibitor (PPI)
  • HALF-LIFE: 0.5–1 hour

Yosprala is omeprazole and aspirin.

Our database has 113 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
HAIR.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RENAL.
RESPIRATORY.
OTHER.


Page last updated 05/08/2023

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top